Volv Global is a pioneering AI-driven healthcare intelligence company, delivering unprecedented insights into rare and difficult-to-diagnose diseases. By leveraging population-scale data, Volv helps clinicians and pharmaceutical innovators recognize undiagnosed patients, detect diseases earlier, predict outcomes, and optimize healthcare pathways. Our custom, proprietary machine learning algorithms power a suite of services for pharmaceutical companies that reduces costs throughout the healthcare ecosystem and improves outcomes for those living with disease. Unlike traditional approaches, Volv’s machine learning methodologies overcome data bias, fragmentation, and standard AI limitations, offering universally adaptable solutions that work across diseases, healthcare systems, and clinical coding environments. With inTrigue, Volv’s proprietary AI technology, the company enables a paradigm shift in disease detection—bringing precision, personalization, and efficiency to healthcare. Volv Global does not hold patient data by design, ensuring privacy-first solutions powered by trusted data processors worldwide. Volv Global website: www.volv.global
Get involved at
World Orphan Drug Congress Europe 2025